C Lavalle

1.8k total citations
38 papers, 1.3k citations indexed

About

C Lavalle is a scholar working on Rheumatology, Pathology and Forensic Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, C Lavalle has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Rheumatology, 7 papers in Pathology and Forensic Medicine and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in C Lavalle's work include Systemic Lupus Erythematosus Research (19 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Peripheral Neuropathies and Disorders (4 papers). C Lavalle is often cited by papers focused on Systemic Lupus Erythematosus Research (19 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Peripheral Neuropathies and Disorders (4 papers). C Lavalle collaborates with scholars based in Mexico, Brazil and United States. C Lavalle's co-authors include Juan B. Kourí, Alicia Graef, Leonor Barile, Marco Antonio Vega‐López, D Alarcón-Segovia, Arturo González‐Robles, Fernando Navarro‐García, Maylin Almonte‐Becerril, Cristina Drenkard and Jorge Sánchez‐Guerrero and has published in prestigious journals such as Journal of Cell Science, The American Journal of Medicine and Annals of the Rheumatic Diseases.

In The Last Decade

C Lavalle

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Lavalle Mexico 18 785 245 220 198 191 38 1.3k
P. Ghillani France 21 833 1.1× 322 1.3× 167 0.8× 164 0.8× 174 0.9× 40 2.3k
Lucio Pallarés Spain 12 528 0.7× 110 0.4× 155 0.7× 118 0.6× 230 1.2× 18 1.3k
P Manganelli Italy 21 601 0.8× 176 0.7× 131 0.6× 39 0.2× 176 0.9× 69 1.5k
Bijal Patel United Kingdom 17 984 1.3× 326 1.3× 175 0.8× 186 0.9× 143 0.7× 35 1.8k
Stuart S. Kassan United States 15 534 0.7× 454 1.9× 103 0.5× 110 0.6× 453 2.4× 19 2.1k
Gary Wright United Kingdom 18 469 0.6× 120 0.5× 97 0.4× 74 0.4× 79 0.4× 65 1.2k
B. R. Hawkins Hong Kong 26 268 0.3× 598 2.4× 212 1.0× 249 1.3× 218 1.1× 73 1.7k
Patrick J. Oliverio United States 11 363 0.5× 192 0.8× 132 0.6× 46 0.2× 143 0.7× 15 896
Antonio Tavoni Italy 22 716 0.9× 218 0.9× 73 0.3× 56 0.3× 367 1.9× 86 1.7k
T Sano Japan 22 216 0.3× 106 0.4× 150 0.7× 279 1.4× 159 0.8× 39 1.3k

Countries citing papers authored by C Lavalle

Since Specialization
Citations

This map shows the geographic impact of C Lavalle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Lavalle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Lavalle more than expected).

Fields of papers citing papers by C Lavalle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Lavalle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Lavalle. The network helps show where C Lavalle may publish in the future.

Co-authorship network of co-authors of C Lavalle

This figure shows the co-authorship network connecting the top 25 collaborators of C Lavalle. A scholar is included among the top collaborators of C Lavalle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Lavalle. C Lavalle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castillo, Elena C., et al.. (2012). Effects of Vitamin D Supplementation during the Induction and Progression of Osteoarthritis in a Rat Model. Evidence-based Complementary and Alternative Medicine. 2012. 1–10. 27 indexed citations
2.
Almonte‐Becerril, Maylin, Fernando Navarro‐García, Arturo González‐Robles, et al.. (2010). Cell death of chondrocytes is a combination between apoptosis and autophagy during the pathogenesis of Osteoarthritis within an experimental model. APOPTOSIS. 15(5). 631–638. 187 indexed citations
3.
Guzmán‐Morales, Jessica, Yazmín Macotela, Juan B. Kourí, et al.. (2006). Prolactin inhibits the apoptosis of chondrocytes induced by serum starvation. Journal of Endocrinology. 189(2). R1–R8. 21 indexed citations
4.
Lavalle, C, et al.. (2004). Trends of anticardiolipin antibodies after low-dose methylprednisolone and cyclophosphamide treatment of systemic lupus erythematosus. Archives of Medical Research. 35(5). 421–426. 4 indexed citations
6.
Escalera, Gonzalo Martı́nez de la, et al.. (2001). Molecular heterogeneity of prolactin in the plasma of patients with systemic lupus erythematosus. Arthritis & Rheumatism. 44(6). 1331–1335. 19 indexed citations
7.
Lavalle, C, et al.. (2000). Reduction in Hospitalization Costs, Morbidity, Disability, and Mortality in Patients with AIDS Treated with Protease Inhibitors. Archives of Medical Research. 31(5). 515–519. 21 indexed citations
8.
Galindo-Rodrı́guez, Griselda, et al.. (1999). Cyclophosphamide pulse therapy in optic neuritis due to systemic lupus erythematosus: an open trial. The American Journal of Medicine. 106(1). 65–69. 48 indexed citations
9.
Baca, Vicente, et al.. (1999). Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus.. PubMed. 26(2). 432–9. 63 indexed citations
10.
Gevorkian, Goar, Tzipe Govezensky, G. Cocho, et al.. (1998). Antigenic Homology of HIV-1 GP41 and Human Platelet Glycoprotein GPIIIa (Integrin β3). Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 17(5). 385–390. 11 indexed citations
11.
Galindo-Rodrı́guez, Griselda, et al.. (1998). Rheumatic manifestations of hematologic disorders. Current Opinion in Rheumatology. 10(1). 86–90. 20 indexed citations
12.
Graef, Alicia, et al.. (1994). High Serum Prolactin Levels in Asymptomatic HIV-Infected Patients and in Patients with Acquired Immunodeficiency Syndrome. Clinical Immunology and Immunopathology. 72(3). 390–393. 13 indexed citations
13.
Lavalle, C, et al.. (1992). Immunoblot assay for detection of autoantibodies in autoimmune disease. Journal of Clinical Laboratory Analysis. 6(5). 319–323. 3 indexed citations
14.
Barile, Leonor & C Lavalle. (1992). Transverse myelitis in systemic lupus erythematosus--the effect of IV pulse methylprednisolone and cyclophosphamide.. PubMed. 19(3). 370–2. 85 indexed citations
15.
Jara, Luis J., C Lavalle, Antonio Fraga, et al.. (1991). Prolactin, immunoregulation, and autoimmune diseases. Seminars in Arthritis and Rheumatism. 20(5). 273–284. 105 indexed citations
16.
Graef, Alicia, et al.. (1991). Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus.. PubMed. 18(3). 349–53. 83 indexed citations
17.
Lavalle, C, et al.. (1990). Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies.. PubMed. 17(1). 34–7. 139 indexed citations
18.
Cruz, Miguel, et al.. (1988). Antinuclear antibodies in scleroderma, mixed connective tissue disease and “primary” Raynaud's phenomenon. Clinical Rheumatology. 7(1). 80–86. 8 indexed citations
19.
Lavalle, C, et al.. (1987). Efectos socioeconomicos de la artritis reumatoide. Revista M�dica del Instituto Mexicano del Seguro Social. 25(4). 269–273.
20.
Lavalle, C, et al.. (1985). Gonadotropins pituitary secretion in systemic lupus erythematosus.. PubMed. 2(2). 163–5. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026